Log In
BCIQ
Print this Print this
 

SP20102

  Manage Alerts
Collapse Summary General Information
Company Sarfez Pharmaceuticals Inc.
DescriptionNot disclosed
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationMyeloproliferative disorder
Indication DetailsTreat cardiac fibrosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today